awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28481370-B2DB4760-57D0-4AE5-B03C-5C2CAA1C3870
Q28481370-B2DB4760-57D0-4AE5-B03C-5C2CAA1C3870
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28481370-B2DB4760-57D0-4AE5-B03C-5C2CAA1C3870
Loss of activating EGFR mutant gene contributes to acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer cells
P2860
Q28481370-B2DB4760-57D0-4AE5-B03C-5C2CAA1C3870
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28481370-B2DB4760-57D0-4AE5-B03C-5C2CAA1C3870
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ce29770dc32de5aef4ef1563584b8d0c1ccc5a5
P2860
Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.